Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database
Philippe Denis1, Antoine Lafuma2, Gilles Berdeaux31Hôpital Edouard Herriot, Lyon, France; 2Cemka, Bourg-la-Reine, France; 3Alcon France, Rueil-Malmaison, FranceAbstract: The persistence and costs of carbonic anhydrase inhibitors + prostaglandin analogues (CAIs + PGAs) vs alpha-2 adrene...
Main Authors: | Philippe Denis, Antoine Lafuma, Gilles Berdeaux |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-06-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/costs-and-persistence-of-alpha-2-adrenergic-agonists-versus-carbonic-a-a1787 |
Similar Items
-
Alpha-adrenergic receptor agonists in terms of modern views on glaucoma monitoring and treatment
by: V.P. Erichev, et al.
Published: (2019-07-01) -
Prostaglandin analogues in angle closure glaucoma
by: Pulkit Gupta, et al.
Published: (2011-01-01) -
Inhibition of the lipolytic action of beta-adrenergic agonists in human adipocytes by alpha-adrenergic agonists.
by: E E Wright, et al.
Published: (1981-11-01) -
Modelling lifetime cost consequences of ReSTOR<sup>® </sup>in cataract surgery in four European countries
by: Berdeaux Gilles, et al.
Published: (2008-07-01) -
Investigation of the mode of action of α-adrenoreceptor agonists and prostaglandins on adrenergic nerve function
by: Elworthy, P. M.
Published: (1978)